Everett, Jeremy R. ORCID: 0000-0003-1550-4482 (2015) Academic drug discovery: Current status and prospects. Expert Opinion on Drug Discovery, 10 (9). pp. 937-944. ISSN 1746-0441 (Print), 1746-045X (Online) (doi:https://doi.org/10.1517/17460441.2015.1059816)

Preview

PDF (Author's Accepted Manuscript) 14880_Everett_Academic drug discover (AAM) 2015.pdf - Accepted Version Download (320kB) | Preview

Abstract

Introduction.
The contraction in pharmaceutical drug discovery operations in the past decade has been counter-balanced by a significant rise in the number of academic drug discovery groups. In addition, pharmaceutical companies that used to operate in completely independent, vertically-integrated operations for drug discovery are now collaborating more with each other, and with academic groups. We are in a new era of drug discovery.

Areas Covered.
This review provides an overview of the current status of academic drug discovery groups, their achievements and the challenges they face,, together with perspectives on ways to achieve improved outcomes.

Expert Opinion.
Academic groups have made important contributions to drug discovery, from its earliest days and continue to do so today. However, modern drug discovery and development is exceedingly complex, and has high failure rates, principally because human biology is complex and poorly understood. Academic drug discovery groups need to play to their strengths and not just copy what has gone before. However, there are lessons to be learnt from the experiences of the industrial drug discoverers and four areas are highlighted for attention: (i) increased validation of targets, (ii) elimination of false hits from HTS, (iii) increasing the quality of molecular probes and (iv) investing in a high quality informatics infrastructure.

Item Type:	Article
Additional Information:	This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Drug Discovery on June 19, 2015, available online: http://www.tandfonline.com/10.1517/17460441.2015.1059816
Uncontrolled Keywords:	Academic, Drug discovery, High throughput screening, HTS, Molecular probes, Pan-assay interference compounds (PAINS)
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	17 Oct 2016 09:14
URI:	http://gala.gre.ac.uk/id/eprint/14880

Actions (login required)

View Item

Downloads